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1. List publications: (a) published and not previously reported; (b) in press. Provide five reprints if not previously submitted. 
2. List all additions and deletions in professional personnel and any changes in effort. 
3. Progress Report. (See Instructions) 
1. (a) Dwight H. Hall, R. Geoffrey Sargent, Kenneth F. Trofatter, and Diane L. 
Russell. Journal of Virology, 36, 103 (1980). Suppressors of Mutations 
in the Bacteriophage T4 Gene Coding for Both RNA Ligase and Tail Fiber 
Attachment Activities. 
Paul M. Macdonald and Dwight H. Hall. Abstracts of papers presented at the 
Bacteriophage Meeting, p. 28 (1980). Mutations in Bacteriophage T4 Genes 
41 and 61 Cause Folate Analog Resistance. 
(b) Dwight H. Hall and Ronald D. Snyder. Genetics (in press, 1980). Suppressors 
of Mutations in the rII Gene of Bacteriophage T4 Affect Promoter Utilization. 
2. None 
3. The long-term goal is to reveal and explain how the genome of phage T4 
is organized, why it is organized that way, and how the sequential expression 
of the genome is regulated. This is being approached by isolating and 
studying T4 mutants affecting genes that determine related enzymes, namely 
those involved in the biosynthesis of thymidylic acid in T4-infected 
Escherichia colt. The aims of the research are: 
(a) to study the relation of these genes to each other and the regulation 
of their expression, 
(b) to further characterize the genes in which mutants have been found, and 
(c) to isolate and study mutants in more T4 genes controlling enzymes 
involved in the synthesis of thymidylate. 
The goals set for the current year were: 
(a) to continue to characterize regulatory far and hus mutants genetically 
and biochemically, especially those that affect the regB gene, 
(b) to further study our temperature-sensitive far mutants, and 
(c) to further understand the mechanism of suppression in our false 
revertants of mutants in gene 63 and its relation to the RNA ligase 
activity of the gene 63 product. 
We have continued to study our folate analog resistant mutant farP13 and 
other mutants affecting the regB gene. Studies of the growth of these T4 
mutants on E. coli mutants with known ribosomal defects indicate that the regB 
 gene product interacts with the ribosomes. Ann Dershowitz has found that these 
T4-induced ribosomal alterations can selectively change T4 gene expression in 
the infected cell. For example, on one strain of E. coli there is reduced 
expression of delayed early genes by both wild type T4 and regB mutants but 
there is reduced expression of an immediate early gene only by the regB mutant. 
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SECTION IV - SUMMARY PROGRESS REPORT (Continued) 
We have studied one of our temperature-sensitive far mutants, farP129, 
and found that it has a mechanism of folate analog resistance quite different 
from any far mutants we have characterized previously. Some of our results 
with this mutant are summarized in the following abstract of a talk given 
at the August, 1980 Bacteriophage Meeting at the Cold Spring Harbor Laboratories 
in New York. 
MUTATIONS IN BACTERIOPHAGE T4 GENES 41 AND 61 CAUSE FOLATE 
ANALOG RESISTANCE. Paul M. Macdonald and Dwight H. Hall, 
School of Biology, Georgia Institute of Technology, Atlanta, 
Georgia 30332 
Plating techniques that eliminate T4 plaque formation 
on Escherichia coli by folate analog inhibition of dihydro-
folate (FH2) reductase allow the isolation of folate analog 
resistant (far) mutants to T4. Many of these far mutants 
have altered synthesis or structure of the T4-induced FH2 
reductase and some of the other mutants are ribonucleotide 
reductase deficient. In order to find new types of T4 mutants, 
we have isolated far mutants at 30°C and screened for those 
unable to grow at 43°C in the absence of folate analogs. 
Only one mutant, farP129, out of over 100 tested, has a single 
mutation causing both folate analog resistance and temperature 
sensitivity. This mutant induces normal levels of FH2 
reductase (coded by the frd gene) and appears to have normal 
expression of other T4 genes at 30°C. The results of 
mapping and complementation studies indicate that the 
farP129 mutation is in gene 41. Like other mutations in 
gene 41, farP129 reduces. phage-induced DNA synthesis to 
about 15% that of wild type T4 as measured by thymidine 
incorporation under restrictive conditions. Surprisingly, 
four other is mutants defective in gene 41 (Caltech 
collection), of four tested, are also far. Three mutants 
defective in gene 61 have beeri tested and all are far 
whereas some other mutants defective in DNA synthesis are 
not far. The phenotypes of double mutants carrying 
mutations in genes 41 and 61, 41 and frd, or 61 and frd 
suggest that the products of these genes interact. 
Our studies of the suppressors of mutations in gene 63 indicate that 
the mechanisms of suppression include delayed lysis and faster addition of 
tail fibers. The genes that the suppressors do affect do not have functions 
with any obvious relation to the RNA ligase activity of the gene 63 product. 
It appears that the major physiological role of the gene 63 product is the 
attachment of tail fibers. 
Page 6 
Dwight H. Hall 
GM 24455-05 
SECTION IV - SUMMARY PROGRESS REPORT (Continued) 
Our studies are providing new types of T4 mutants affecting related 
functions. Characterization of these mutants, some of which are regulatory, 
is leading to a better understanding of the organization and expression of 
the T4 genome. 
A knowledge of the mechanisms involved in the control of phage develop-
ment in infected bacteria should be helpful in'the analysis of growth and 
development of higher organisms. It is conceivable that in some cases very 
similar mechanisms may be found. For example, it has been suggested that 
some of the enzymes involved in thymidylate synthesis are under coordinate 
control in mammalian cells just as they may be in T4-infected E. coli. An 
understanding of the phage genome may help in studying controlled and 
uncontrolled growth in higher organisms. 
Some mutants are being recognized by their resistance or sensitivity 
to inhibitors of nucleotide metabolism, such as hydroxyurea and folate 
analogs, and are providing new insights into mechanisms of drug action and 
resistance. 
The research goals for the coming year are: 
(a) to further characterize regulatory far and hus mutants genetically 
and biochemically, especially those that affect the regB gene, 
(b) to further understand the mechanisms of suppression in our false 
revertants of mutants in gene 63 and its relation to the RNA 
ligase activity of the gene 63 product and to the pseT gene. 
(c) to isolate and characterize more far mutants of different types, 
particularly temperature-sensitive mutants and mutants derived 
from E. coli strains containing T4-plasmid hybrids. 
The undersigned agrees to accept responsibility for the scientific 
and technical conduct of the project and for provision of required progress 
reports if a grant is awarded as the result of this application. 
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